Oura launches Ring 5 with a focus on healthcare and prepares public offering valued at US$11 billion

The company Oura Health Oy has officially announced the arrival of the Ring 5 to the global wearable device market. The new smart ring features reduced dimensions compared to previous models and incorporates advanced sensors for continuous monitoring of biometric data. The Finnish-American manufacturer confirmed that the first units will begin shipping to consumers from June 4th. The launch occurs at a strategic moment for the technology company, which seeks to consolidate its leadership in the digital health sector.
With an established base of active users, the organization is structuring its initial public offering (IPO) for the coming months. The company’s market valuation reached the $11 billion mark recently, driven by consistent financial results. The economic movement reflects the significant increase in demand for discreet health monitors and the expansion of the smart ring sector. Este specific segment has attracted both traditional wristwatch consumers and new preventive technology enthusiasts.
Miniaturized Design and new monitoring metrics
The Oura Ring 5 engineering project prioritized the physical reduction of internal components without compromising processing capacity. The device is just 2.28 millimeters thick. The measured Esta represents a 40% decrease in total volume when compared to the predecessor model, the Ring 4. The structural change brings the shape of the equipment closer to that of a conventional piece of jewelry, facilitating uninterrupted use. The internal battery has also undergone significant upgrades. The component now supports longer periods away from the magnetic charger.
The device’s sensor system has been recalibrated to record body information with high precision during the day and night. The suite of features covers different aspects of the user’s physical and mental well-being, operating passively in the background.
- Monitoramento detailed sleep stages
- Avaliação continuous daily stress levels
- Análise of physical and mental readiness for activities
- Acompanhamento of heart health indicators
- Core Body Temperature Medição for Cycle Tracking and Menopause
Oura’s product director, Holly Shelton, classified the equipment as the most capable wearable device ever developed by the brand. The model will be sold with a starting price of US$399, equivalent to €399 or £399 on the European market, and A$649 on Austrália. Full access to historical data and advanced analytics requires maintaining a monthly subscription. The service costs US$5.99 on Estados Unidos.
Crescimento financial and preparation for IPO
The manufacturer’s commercial trajectory recorded a significant acceleration in the latest corporate balance sheets. The company’s revenue multiplied four times in just two years. The company will reach the US$1 billion revenue mark by the year 2025. Esse robust economic performance supports the US$11 billion valuation established for the imminent listing on the stock exchange. The strategy of initially focusing on sleep quality as a fundamental pillar helped the brand dominate a specific niche before expanding into other areas of preventive medicine.
The business model based on recurring subscriptions has proven to be highly profitable for the company’s structure. The platform currently has around 5 million active paying subscribers around the world. Internal statistics reveal that 80% of members choose to renew the service after the first year of use. Daily engagement also shows high rates. Wearers keep the ring on their finger for an average of 23.5 hours a day.
The marketing director of FDM CCS Insight, Ben Wood, analyzed the behavior of consumers in this technological segment. The executive highlighted that the public perceives real value in the service due to the application’s constant updates. The clarity of the health metrics messages and the ease of interpreting the graphs justify the monthly cost for most customers. The company managed to capitalize on gaps left by technology giants, such as Apple, by offering a less invasive format.
Global Expansão and Smart Device Market Adoption
Fundada in the year 2013 in the city of Oulu, in Finlândia, the company started its large-scale commercial operations through a campaign on the Kickstarter platform in 2015. The founders Petteri Lahtela, Markku Koskela and Kari Kivela utilized previous experience in companies like Nokia and Polar to develop the first generation of the product. Initial fundraising exceeded $650,000. Desde then, the startup sold 5.5 million units, distributed across 150 countries over four generations of hardware.
The current workforce exceeds 1,200 direct employees. The corporate structure, now led by an American CEO, maintains strategic offices at Helsinque, Londres, Los Angeles and San Diego. Main headquarters operate at São Francisco and Oulu. The research and development department continues to be mainly concentrated in the Finnish city of origin, maintaining the brand’s technological roots.
The global smart ring market reached 4 million units sold in 2025 alone. The volume represents double that recorded in the previous two years, according to data from FDM CCS Insight. Embora the number is modest compared to the 175 million smartwatches sold in the same period, the category attracts a highly diverse audience. The brand’s visibility increased significantly after personalities such as Jennifer Aniston, Gwyneth Paltrow, Kim Kardashian and Príncipe Harry publicly adopted the accessory. The company has also entered into more than 1,200 institutional partnerships, including agreements with Football Association, the Finnish Olympic team, US Soccer and the US Open tournament.
Atualizações software and focus on preventive healthcare
Oura’s development strategy moves beyond hardware manufacturing, with heavy investments in predictive algorithms and data intelligence. The company is preparing to introduce a system called health radar. The tool is designed to alert users to potential physiological abnormalities before overt clinical symptoms emerge. The software can identify subtle variations in blood pressure and interruptions in breathing patterns during night rest.
The application will also receive specific modules to accompany contemporary medical treatments. The interface will provide detailed analysis on the use of GLP-1 class drugs, widely used for weight loss and metabolic control. The feature will allow patients to monitor the long-term physiological effects of doses. The system will cross-reference this information with the readiness and physical recovery data recorded daily by the ring.
The specific needs of the female audience continue to receive priority attention from the software engineering team. Core body temperature monitoring has been improved to provide more accurate predictions about the menstrual cycle and the different phases of menopause. The demographic division of users, which according to research by FDM CCS Insight is almost equal between genders, justifies the allocation of resources to inclusive features. The manufacturer’s objective is to ensure that the device meets different biological profiles with the same level of precision and practical usefulness in everyday life.







